Micro Emerging Active

Prezzo obiettivo di ABUS ridotto per maggiore probabilità di ricorso

New narrative with limited coverage — still forming.

Punteggio
0,5
Velocità
▲ 1,0
Articoli
1
Fonti
1

Sentiment Timeline

Event Timeline

Apr 18, 2026
Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal … Neutral

Articoli Correlati

Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability

Yahoo Finance · Apr 18, 2026
Mixed

Cronologia

Ultimo aggiornamentoApr 18, 2026